Methotrexate

Verify pregnancy status in females of reproductive potential before starting Methotrexate Injection., Neoplastic diseases: Refer to the prescribing information for disease specific dosing recommendations.

Directions from the U.S. FDA-approved label — your doctor or pharmacist may advise differently.

Methotrexate Injection is contraindicated in: Patients with history of severe hypersensitivity to methotrexate., Pregnancy in patients with non-neoplastic diseases., History of severe hypersensitivity to methotrexate., Pregnancy: in patients with non-neoplastic diseases.

Excerpt from the U.S. FDA-approved label. Talk to a pharmacist or doctor before use.

Secondary malignancies can occur., Tumor lysis syndrome can occur in patients with rapidly growing tumors., Immunizations and Risks associated with Live Vaccines: Immunizations may be ineffective. Live vaccines are not recommended due to risk of disseminated infection., Infertility: Can cause impairment of fertility, oligospermia, and menstrual dysfunction. 5.1 Embryo-Fetal Toxicity Based on published reports and its mechanism of action, methotrexate can cause embryo-fetal toxicity, including fetal death when administered to a pregnant woman.

Warnings and precautions excerpt from the U.S. FDA-approved label — not a complete list. Talk to a pharmacist or doctor before use.

The following adverse reactions are described, or described in greater detail, in other sections: Hypersensitivity Reactions, Myelosuppression, Serious Infections, Renal Toxicity, Hepatotoxicity, Neurotoxicity, Gastrointestinal Toxicity, Pulmonary Toxicity, Dermatologic Reactions, Secondary Malignancies, Tumor Lysis Syndrome, Increased Risk of Adverse Reactions due to Third-Space Accumulation Common adverse reactions include…

Excerpt from the U.S. FDA-approved label — not a complete list. Talk to a pharmacist or doctor about side effects.

180 products from 68 makers in the NepalDoc medicine catalog use this generic:

Showing 30 of 180 catalog products. Search the full catalog in the app.

Brand list from the NepalDoc medicine catalog. Availability varies by pharmacy — call ahead to confirm stock.

Store at 20°C to 25°C (68°F to 77°F); excursions permitted to 15°C to 30°C (59°F to 86°F). Protect from light. After first puncture, store multiple-dose vials at 2°C to 8°C, and use within 30 days. Methotrexate Injection is a hazardous drug. Follow applicable special handling and disposal procedures.

Storage information from the U.S. FDA-approved label.